Jeong Eun Sohn

Dr. Jeong Eun Sohn

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2022 in Applied Sciences
Verified
Journal Article
Open access
PDF file
JPJung Heum Park
Jung Heum Park
JWJeong Hwan Wi
Jeong Hwan Wi
TKTae Seob Kim
Tae Seob Kim
SKSeung Soo Kim
Seung Soo Kim
CJCheol Jeong
Cheol Jeong
RKRobert Kim
Robert Kim
It is allegedly known that the thermal stability of the Mint Lift® (the Mint Lift® 17 and the Mint Lift® Fine; HansBiomed Co., Ltd., Seoul, Korea) over time might be lower as compared with thread-lifts processed through ultrasonic molding technology, such as the MEDI ROPE (WSM 19-03; CNG Co., Ltd., Gyeonggi, Korea), because the Mint Lift® undergoes a thermal treatment during the manufacturing process. We conducted this accelerated aging test to compare the thermal stability over time between the Mint Lift® and the MEDI ROPE. Thus, we measured the degrees of strength of the MEDI ROPE, the Mint Lift® 17, and the Mint Lift® Fine at 0, 2, 3, 4, 5, 7, 8, 9, 10, 11, 14, and 17 weeks. Between 0 and 14 weeks, the Mint Lift® 17 and the Mint Lift® Fine had significantly higher degrees of strength as compared with the MEDI ROPE (p < 0.05). At 0, 5, and 10 weeks, the Mint Lift® 17 and the Mint Lift® Fine showed no notable differences in microscopic findings as compared with the MEDI ROPE. At 20 weeks, however, the integrities of the Mint Lift® 17 and the Mint Lift® Fine were better preserved as compared with the MEDI ROPE. In conclusion, our results indicate that the Mint Lift® 17 and the Mint Lift® Fine might be less vulnerable to degradation over time as compared with the MEDI ROPE under thermal conditions.

10 February 2022 in Medicina
Verified
Journal Article
Open access
PDF file
SJSeong Hoon Jung
Seong Hoon Jung
DKDae-Hwan Kim
Dae-Hwan Kim
JSJeong Eun Sohn
Jeong Eun Sohn
Central venous cannulation (CVC) is a procedure that is frequently performed to facilitate resuscitation, nutritional support and long-term vascular access. It may often cause mechanical complications during placement of a cannula in association with the anatomical relationship with central veins. A 68-year-old man visited our medical institution with a chief complaint of foreign-body-induced esophageal perforation. This patient presented with bleeding of the superior vena cava due to an iatrogenic injury to it during the CVC in the right internal jugular vein. Our case indicates that it would be mandatory to insert a cannula at an optimal depth considering the anatomical relationship between the central veins during the CVC.

13 March 2026 in Ewha Medical Journal
Verified
Journal Article
Open access
HKHyuk Soon Kim
Hyuk Soon Kim
DKDae Hwan Kim
Dae Hwan Kim
YNYunyoung Nam
Yunyoung Nam
JSJeong Eun Sohn
Jeong Eun Sohn
GNGeunwoong Noh
Geunwoong Noh
Nociceptive pain as a clinical presentation of chronic urticaria and disappearance with immunoglobulin/histamine complex therapy: a case report

6 March 2022 in Medicina
Verified
Journal Article
Open access
PDF file
YSYu Kwan Song
Yu Kwan Song
JKJo Yong Kyu
Jo Yong Kyu
JSJeong Eun Sohn
Jeong Eun Sohn
RKRobert Kim
Robert Kim
Background and objectives: We examined whether there is a significant correlation between inflammatory markers and the wound healing rate (WHR) in diabetic patients. Materials and Methods: A total of 60 patients were divided into two groups depending on the completion of wound healing (WH) at 5 weeks: the early WH group (period of WH < 5 weeks; n = 27) and the late WH group (period of WH > 5 weeks; n = 33). The baseline characteristics and wound measurements were compared between the two groups. To identify the correlation between inflammatory markers (e.g., white blood cell counts (WBCs), serum C-reactive protein (CRP) levels and erythrocyte sedimentation rate (ESR)) and WHR, we performed a Pearson correlation analysis. Results: The WHR was 8.06 ± 4.02 mm2/day in the early WH group and 2.71 ± 0.88 mm2/day in the late group. This difference reached statistical significance (p < 0.001). Moreover, WBC counts were significantly higher and serum levels of CRP and ESR were significantly lower in the early WH group than in the late group (p = 0.027, 0.036 and 0.043, respectively). Conclusions: Our results indicate that WBC as well as serum CRP and ESR levels have a significant correlation with WHR in diabetic patients.

30 June 2022 in Journal of Trauma and Injury
Verified
Journal Article
Open access
PDF file
TLTae Yeon Lee
Tae Yeon Lee
JOJeong Woo Oh
Jeong Woo Oh
MLMin Koo Lee
Min Koo Lee
JKJoong Suck Kim
Joong Suck Kim
JSJeong Eun Sohn
Jeong Eun Sohn
JWJeong Hwan Wi
Jeong Hwan Wi
Purpose: Ventilator-associated pneumonia is the most common nosocomial infection in patients with mechanical ventilation. In 2013, the new concept of ventilator- associated events (VAEs) replaced the traditional concept of ventilator-associated pneumonia. We analyzed risk factors for VAE occurrence and in-hospital mortality in trauma patients who received mechanical ventilatory support.Methods: In this retrospective review, the study population comprised patients admitted to the Jeju Regional Trauma Center from January 2020 to January 2021. Data on demographics, injury characteristics, and clinical findings were collected from medical records. The subjects were categorized into VAE and no-VAE groups according to the Centers for Disease Control and Prevention/National Healthcare Safety Network VAE criteria. We identified risk factors for VAE occurrence and in-hospital mortality.Results: Among 491 trauma patients admitted to the trauma center, 73 patients who received ventilator care were analyzed. Patients with a chest Abbreviated Injury Scale (AIS) score ≥3 had a 4.7-fold higher VAE rate (odds ratio [OR], 4.73; 95% confidence interval [CI], 1.46–17.9), and those with a glomerular filtration rate (GFR) <75 mL/min/1.73 m2 had 4.1-fold higher odds of VAE occurrence (OR, 4.15; 95% CI, 1.32–14.1) and a nearly 4.2-fold higher risk for in-hospital mortality (OR, 4.19; 95% CI, 1.30–14.3). The median VAE-free duration of patients with chest AIS ≥3 was significantly shorter than that of patients with chest AIS <3 (P=0.013).Conclusions: Trauma patients with chest AIS ≥3 or GFR <75 mL/min/1.73 m2 on admission should be intensively monitored to detect at-risk patients for VAEs and modify the care plan accordingly. VAEs should be closely monitored to identify infections early and to achieve desirable results. We should also actively consider modalities to shorten mechanical ventilation in patients with chest AIS ≥3 to reduce VAE occurrence.

9 August 2026 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
HKHyuk Soon Kim
Hyuk Soon Kim
YNYunyoung Nam
Yunyoung Nam
JSJeong Eun Sohn
Jeong Eun Sohn
GNGeunwoong Noh
Geunwoong Noh
Fibromyalgia (FM) is a chronic pain syndrome characterized by widespread musculoskeletal pain, often accompanied by fatigue, sleep disturbance, and cognitive symptoms. Although several treatment options are available, no curative therapy has been established. Histobulin is a histamine‐fixed immunoglobulin preparation developed to regulate serum histamine levels through histaminopexy. It has been reported to have therapeutic effects in allergic rhinitis, bronchial asthma, chronic urticaria, and atopic dermatitis. We report a patient with FM and concomitant chronic urticaria and allergic rhinitis who experienced improvement in FM after Histobulin therapy. A 39‐year‐old Korean woman presented with a 6‐year history of chronic urticaria, allergic rhinitis with rhinorrhea, and widespread musculoskeletal pain. She had previously been diagnosed with FM and had received oral treatment for pain for 13 months. At the first visit, her widespread pain index (WPI) was 9 and her symptom severity scale (SSS) score was 12. Histobulin therapy was initiated primarily for chronic urticaria and allergic rhinitis. During treatment, she reported reductions in widespread pain, finger stiffness, and insomnia, as well as improved daily functioning and reduced use of rescue analgesics. After six injections, the patient reported marked reductions in FM symptoms and in symptoms of urticaria and rhinitis. No recurrence was reported during the subsequent 3‐week follow‐up period. FM symptoms improved after Histobulin therapy initiated for chronic urticaria and allergic rhinitis. This observation suggests that modulation of histamine‐related or immune pathways may be associated with clinical improvement. However, causality cannot be established from a single case report, and further controlled studies are required.